Report: Strategic Patent Extensions Could Add Billions to Pharmaceutical Revenue

A new report examines patent strategies employed by leading pharmaceutical companies to extend the market life of blockbuster drugs. The report highlights the potential for significant profit increases through strategic patent management, including identifying and leveraging patent loopholes, constructing robust patent portfolios, and proactively addressing competitive challenges. The report suggests that pharmaceutical companies can potentially add billions to their revenue by strategically extending the life of a drug through patent extensions. It also details methods for building stronger patent portfolios that will further protect pharmaceutical companies from competitors. Further, the report outlines how pharmaceutical companies can preemptively maneuver against competitors to maintain market leadership and revenue streams. The full report is available for download at drugpatentwatch.com.

Newsflash | Powered by GeneOnline AI
Date: April 15, 2025

Related posts:

Data Clean Rooms Revolutionize Secure Healthcare Data Sharing VERVE-102 Phase Ib Trial Shows LDL-C Reduction, Different Safety Profile Than VERVE-101 Generic Drug Makers Aim to Cut Costs and Lead Market with Strategies Including Supply Chain Optimization, According to DrugPatentWatch Innovative approach could improve cancer immunotherapy

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後